Changing natalizumab dosing frequency reduced risk for PML

A board to discuss the newly-released drug Tysabri, (formerly known as Antegren) as a treatment for Multiple Sclerosis

Changing natalizumab dosing frequency reduced risk for PML

Postby MSUK » Wed Feb 07, 2018 3:21 am

Changing natalizumab dosing frequency reduced risk for Progressive Multifocal Leukoencephalopathy (PML)

A commonly-prescribed multiple sclerosis (MS) infusion medication linked to a rare but serious side effect is safer to use when dosing intervals are extended, according to a new study led by MS specialists at NYU Langone Health in New York…Read more - http://www.ms-uk.org/changing-natalizumab-dosing-frequency-reduced-risk-progressive-multifocal-leukoencephalopathy-pml

Image
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2903
Joined: Wed Oct 14, 2009 2:00 pm

Advertisement

Re: Changing natalizumab dosing frequency reduced risk for P

Postby ElliotB » Wed Feb 07, 2018 5:45 am

I have to wonder why anyone would take a medication known to cause or potentially cause something as serious as PML. This is not the only medication that has this very, very serious risk.
ElliotB
Family Elder
 
Posts: 1601
Joined: Mon Feb 03, 2014 4:08 pm


Return to Tysabri (Antegren or Natalizumab)

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service